24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
pharmaceutical
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:12
Israel’s tech exports hit a record but foreign owners are claiming more of the gains
16:55
Full list of Israeli high-tech funding rounds in 2026
16:52
Sayeret Matkal veterans raise $22 million to teach the world English with AI
15:11
SentinelOne CEO sells $2.29 million in shares as stock closes in on its yearly high
More stories
Buzz
Most popular
Daily
Weekly
1
Buildots raises $130 million at nearly $1 billion valuation as AI boom drives data center construction
2
How an Israeli engineer went from Rafael to iPhone Portrait Mode and a $300 million OpenAI exit
3
Oracle’s AI transformation gets more expensive as layoffs continue
4
OpenAI acquires Israeli-founded camera startup Glass Imaging for over $300 million
5
Oracle begins another round of layoffs as $2.8 billion restructuring plan expands
More news
pharmaceutical
4 stories about pharmaceutical
Life Sciences Venture Fund aMoon Closes Second Fund at $660 Million
06.03.19
|
Hagar Ravet
The second fund will focus on mid to late-stage health companies in the domains of pharma, digital health, and medical technology
Regulation Hinders Innovative Drug Development in Israel, Executives Say
04.09.17
|
Naomi Zoreff
Despite Israel's advanced medical infrastructure, excessive red tape steers pharmaceutical companies away
Developer Of Anti-Rabies Drug Jumps on FDA Approval
27.08.17
|
Dror Reich
The plasma-derived drug is used together with the rabies vaccine to treat unvaccinated persons exposed to the virus
U.S. Congress to Investigate Rising Multiple Sclerosis Drug Prices
21.08.17
|
Dror Reich
Two Congressmen are looking into the rising MS drug prices of seven pharmaceutical companies